Effect of Dexmedetomidine Upon Sleep Postoperatively

Sponsor
Duke University (Other)
Overall Status
Withdrawn
CT.gov ID
NCT00333632
Collaborator
(none)
0
1
60
0

Study Details

Study Description

Brief Summary

The purpose of this study is to determine whether an intravenous infusion of dexmedetomidine administered to surgical patients intra-operatively will improve the characteristics of sleep post-operatively.

Condition or Disease Intervention/Treatment Phase
Phase 4

Detailed Description

Physiological similarities exist between the anesthetized state and sleep. Pathways within the brain controlling sleep and wakefulness are also affected by anesthesia. One significant difference between the states of anesthesia and sleep is the ability to respond whenever a relatively mild stimulus is applied, e.g. verbal command or gently shaking. Interestingly, this feature of arousability is seen when dexmedetomidine is used for sedation but is absent when alternative intravenous anesthetic agents, e.g. propofol, are used to provide similar degree of sedation. Recent studies have shown that dexmedetomidine acts on receptors located within the locus ceruleus, which are responsible for both sleep and anesthesia.

During a recent study volunteers received an infusion of dexmedetomidine during the afternoon prior to remaining under study conditions for the duration of the night. The study was not designed to measure sleep but anecdotal reporting from the participants suggested that they were able to resume their normal day's activities whilst the subject receiving placebo felt extremely fatigued from lack of sleep. This prompted the establishment of a pilot study to determine if dexmedetomidine could provide restorative sleep to people under disturbed sleep conditions i.e. postoperative patients.

Study Design

Study Type:
Interventional
Actual Enrollment :
0 participants
Allocation:
Randomized
Intervention Model:
Single Group Assignment
Masking:
Double
Primary Purpose:
Treatment
Official Title:
Restorative Sleep: Effect of Dexmedetomidine
Study Start Date :
Jun 1, 2006
Actual Study Completion Date :
Jun 1, 2011

Outcome Measures

Primary Outcome Measures

  1. Measurements of sleep quality during postoperative period:Epworth Sleepiness Scale []

  2. Completion of sleep log []

  3. Subjects will also be asked to complete Visual Analogue Scales (VAS) of sleep and daytime sleepiness. []

Secondary Outcome Measures

  1. The quality of postoperative recovery (QoR) and the presence of fatigue (Brief Fatigue Inventory) []

  2. Subjects will also be asked to complete Visual Analogue Scale (VAS) of fatigue. []

Eligibility Criteria

Criteria

Ages Eligible for Study:
21 Years to 50 Years
Sexes Eligible for Study:
All
Accepts Healthy Volunteers:
No
Inclusion Criteria:
  • scheduled to undergo elective lower extremity orthopaedic surgery (free vascular fibular graft)

  • ASA 1 or 2

  • Body Mass Index 20 - 30

  • Procedure to be done under combined epidural and general anesthesia

Exclusion Criteria:
  • Sleep disturbance

  • Insomnia

  • Sleep apnea

  • Female (pregnant)

  • Contra-indication to placement of epidural anesthesia

Contacts and Locations

Locations

Site City State Country Postal Code
1 Duke University Medical Center Durham North Carolina United States 27710

Sponsors and Collaborators

  • Duke University

Investigators

  • Principal Investigator: David B MacLeod, MD, Duke University

Study Documents (Full-Text)

None provided.

More Information

Publications

None provided.
Responsible Party:
Duke University
ClinicalTrials.gov Identifier:
NCT00333632
Other Study ID Numbers:
  • Pro00007964
  • 8306
First Posted:
Jun 6, 2006
Last Update Posted:
Jul 14, 2014
Last Verified:
Jun 1, 2011
Keywords provided by Duke University
Additional relevant MeSH terms:

Study Results

No Results Posted as of Jul 14, 2014